glp 1 lawsuit update Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Novo Nordisk Lawsuit Targets Eli

doi: 10.1016/j.fhfh.2022.100110 214

We suggest that the role of the kidney is crucial for the effect of SGLT-2i on the clinical outcomes not only because these drugs slow-down the time-dependent decline of kidney function and enhance the response to diuretics, but also because they attenuate the meal-related anti-natriuretic pressure (lowering postprandial hyperglycemia and hyperinsulinemia and preventing proximal sodium reabsorption), which would reduce the individual sensitivity to day-to-day variations in dietary sodium intake

Increased Cost: Usually more costly as a result of cutting-edge technology

So its also like kind of interesting, you know, Im I very often will have somebody on, you know, a half of a statin or, you know, like, I mean, you know, will adjust things, you know, based on their digestion or based on, you know, things that we call out

T., Xuan, L., Lin, L